tradingkey.logo

Teva And Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement To Advance Duvakitug

ReutersMar 3, 2026 10:40 PM

- Teva Pharmaceutical Industries Ltd TEVA.TA:

  • TEVA AND BLACKSTONE LIFE SCIENCES ANNOUNCE $400 MILLION STRATEGIC GROWTH CAPITAL AGREEMENT TO ADVANCE DUVAKITUG

  • TEVA: AS PART OF FUNDING ARRANGEMENT, TEVA WILL PAY BXLS A MILESTONE PAYMENT FOR DUVAKITUG

  • TEVA: BXLS ALSO ELIGIBLE TO RECEIVE COMMERCIAL MILESTONES & LOW SINGLE-DIGIT ROYALTIES ON DUVAKITUG WORLDWIDE SALES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI